| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.
|
Antimicrob Agents Chemother
|
2005
|
3.87
|
|
2
|
Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.
|
Clin Infect Dis
|
2003
|
3.20
|
|
3
|
Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.
|
Antimicrob Agents Chemother
|
2007
|
2.42
|
|
4
|
Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae.
|
Antimicrob Agents Chemother
|
2004
|
2.20
|
|
5
|
Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
|
Infect Control Hosp Epidemiol
|
2004
|
2.05
|
|
6
|
Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
|
Antimicrob Agents Chemother
|
2004
|
2.02
|
|
7
|
Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis in immunocompromised patients.
|
Am J Med
|
2009
|
1.71
|
|
8
|
Prediction of residual immunity to smallpox, by means of an intradermal skin test with inactivated vaccinia virus.
|
J Infect Dis
|
2006
|
1.50
|
|
9
|
Diagnostic usefulness of a T-cell based assay for extrapulmonary tuberculosis.
|
Arch Intern Med
|
2007
|
1.49
|
|
10
|
A comparative study of pyogenic and tuberculous spondylodiscitis.
|
Spine (Phila Pa 1976)
|
2010
|
1.41
|
|
11
|
Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.
|
Clin Infect Dis
|
2003
|
1.39
|
|
12
|
Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.
|
J Korean Med Sci
|
2006
|
1.31
|
|
13
|
Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa.
|
Microb Drug Resist
|
2005
|
1.18
|
|
14
|
Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
|
J Antimicrob Chemother
|
2004
|
1.16
|
|
15
|
Microbiologically and clinically diagnosed vertebral osteomyelitis: impact of prior antibiotic exposure.
|
Antimicrob Agents Chemother
|
2012
|
1.15
|
|
16
|
Diagnosis of central nervous system tuberculosis by T-cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells.
|
Clin Vaccine Immunol
|
2008
|
1.11
|
|
17
|
Treatment failure due to emergence of resistance to carbapenem during therapy for Shewanella algae bacteremia.
|
J Clin Microbiol
|
2006
|
1.09
|
|
18
|
Outcomes of Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia.
|
Infect Control Hosp Epidemiol
|
2003
|
1.07
|
|
19
|
Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome.
|
Clin Infect Dis
|
2004
|
1.02
|
|
20
|
Bacteremia is a prognostic factor for poor outcome in spontaneous bacterial peritonitis.
|
Scand J Infect Dis
|
2007
|
1.00
|
|
21
|
Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase.
|
J Antimicrob Chemother
|
2004
|
0.97
|
|
22
|
Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial.
|
J Infect Dis
|
2005
|
0.95
|
|
23
|
A case of hypersensitivity syndrome to both vancomycin and teicoplanin.
|
J Korean Med Sci
|
2006
|
0.93
|
|
24
|
Detailed kinetics of immune responses to a new cell culture-derived smallpox vaccine in vaccinia-naïve adults.
|
Vaccine
|
2007
|
0.88
|
|
25
|
A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteers.
|
Vaccine
|
2010
|
0.88
|
|
26
|
Incidence and risk factors of tuberculosis in patients with human immunodeficiency virus infection.
|
J Korean Med Sci
|
2013
|
0.86
|
|
27
|
Clinical epidemiology of ciprofloxacin resistance and its relationship to broad-spectrum cephalosporin resistance in bloodstream infections caused by Enterobacter species.
|
Infect Control Hosp Epidemiol
|
2005
|
0.83
|
|
28
|
The burden of nosocomial staphylococcus aureus bloodstream infection in South Korea: a prospective hospital-based nationwide study.
|
BMC Infect Dis
|
2014
|
0.80
|
|
29
|
Chronic cutaneous disseminated Trichosporon asahii infection in a nonimmunocompromised patient.
|
J Am Acad Dermatol
|
2008
|
0.79
|
|
30
|
Differentiating rapid- and slow-growing mycobacteria by difference in time to growth detection in liquid media.
|
Diagn Microbiol Infect Dis
|
2012
|
0.78
|
|
31
|
Cell-mediated immune responses to smallpox vaccination.
|
Clin Vaccine Immunol
|
2006
|
0.75
|